Vertoon slegs
0:07
S… Speaker 1 (Voice 002)
My name is Mayer.
0:20
S… Speaker 4 (Voice 002)
My name is Mayer.
0:22
S… Speaker 4 (Voice 002)
My presentation is confirmed.
0:24
S… Speaker 4 (Voice 002)
Difference in personal personal precision medicine.
0:27
S… Speaker 1 (Voice 002)
How is that?
0:29
S… Speaker 3 (Voice 002)
It's a lot of people.
0:31
S… Speaker 4 (Voice 002)
If you tell me that you refer to EBI,
0:36
S… Speaker 4 (Voice 002)
then I will come to two presentations and chapters.
0:39
S… Speaker 4 (Voice 002)
My name is Mayer.
0:42
S… Speaker 4 (Voice 002)
My name is Mayer.
0:44
S… Speaker 4 (Voice 002)
My name is Mayer.
0:47
S… Speaker 1 (Voice 002)
I will give you just for now.
0:51
S… Speaker 1 (Voice 002)
It is appearing as a sub-question.
0:53
S… Speaker 3 (Voice 002)
There is a question.
0:55
S… Speaker 1 (Voice 002)
But it shouldn't appear as a sub-question.
0:56
S… Speaker 1 (Voice 002)
Because what is the major thing?
1:00
S… Speaker 3 (Voice 002)
So one,
1:02
S… Speaker 1 (Voice 002)
it indicates sub-questions.
1:14
S… Speaker 1 (Voice 002)
There is a question,
1:16
S… Speaker 1 (Voice 002)
meaning how I make the questions.
1:19
S… Speaker 1 (Voice 002)
I am here with you 15 marks.
1:23
S… Speaker 1 (Voice 002)
I am here with you 15 marks.
1:28
S… Speaker 1 (Voice 002)
You will change my question paper.
1:30
S… Speaker 1 (Voice 002)
It is like changing my question paper.
1:32
S… Speaker 3 (Voice 002)
Oh, thank you.
1:36
S… Speaker 1 (Voice 002)
You can't do it every time.
1:37
S… Speaker 1 (Voice 002)
It is one question.
1:39
S… Speaker 1 (Voice 002)
There is one question.
1:43
S… Speaker 1 (Voice 002)
But in that you have two sub-questions.
1:45
S… Speaker 1 (Voice 002)
This indicates there is a sub-question.
1:47
S… Speaker 1 (Voice 002)
How can you change that part?
1:52
S… Speaker 1 (Voice 002)
In a different way.
1:53
S… Speaker 1 (Voice 002)
In a different way.
1:56
S… Speaker 1 (Voice 002)
There is no one-two.
1:58
S… Speaker 1 (Voice 002)
But I still have sub-sections.
2:00
S… Speaker 1 (Voice 002)
There is a specific meaning to it.
2:04
S… Speaker 1 (Voice 002)
You will change it to creative problem for me.
2:06
S… Speaker 1 (Voice 002)
You will change my question.
2:07
S… Speaker 1 (Voice 002)
What do you do now?
2:08
S… Speaker 1 (Voice 002)
When I have questions like this.
2:11
S… Speaker 1 (Voice 002)
You are not supposed to change multiple times.
2:12
S… Speaker 1 (Voice 002)
What do you do now?
2:33
S… Speaker 2 (Voice 002)
Data privacy.
2:34
S… Speaker 2 (Voice 002)
Risk assessment.
2:36
S… Speaker 1 (Voice 002)
Agriculture.
2:49
S… Speaker 2 (Voice 002)
Holy genome sequencing.
2:50
S… Speaker 2 (Voice 002)
Receipt file formatting.
2:53
S… Speaker 2 (Voice 002)
Exxonium.
2:57
S… Speaker 2 (Voice 002)
Workflow.
3:19
S… Speaker 3 (Voice 002)
Precision.
3:19
S… Speaker 4 (Voice 002)
Precision medicine.
3:21
S… Speaker 4 (Voice 002)
Any personalized medicine.
3:23
S… Speaker 4 (Voice 002)
Difference between them.
3:25
S… Speaker 4 (Voice 002)
And its role and interests.
8:24
S… Speaker 1 (Voice 002)
Yes, ma'am.
9:15
S… Speaker 1 (Voice 002)
Yes, ma'am.
9:15
S… Speaker 1 (Voice 002)
Yes, ma'am.
9:16
S… Speaker 1 (Voice 002)
Yes, ma'am.
9:25
S… Speaker 1 (Voice 002)
Yes, ma'am.
9:36
S… Speaker 1 (Voice 002)
It is a very simple resource.
9:53
S… Speaker 1 (Voice 002)
This exam is going to be 1.
9:55
S… Speaker 1 (Voice 002)
1.
9:56
S… Speaker 1 (Voice 002)
1.
9:56
S… Speaker 1 (Voice 002)
1.
9:57
S… Speaker 1 (Voice 002)
1.
9:58
S… Speaker 1 (Voice 002)
1.
9:58
S… Speaker 2 (Voice 002)
1.
9:59
S… Speaker 1 (Voice 002)
1.
9:59
S… Speaker 1 (Voice 002)
1.
9:59
S… Speaker 1 (Voice 002)
1.
9:59
S… Speaker 1 (Voice 002)
1.
10:00
S… Speaker 1 (Voice 002)
Yes, in the afternoon session.
10:03
S… Speaker 1 (Voice 002)
Ma'am, let me explain the DEG.
10:06
S… Speaker 1 (Voice 002)
No, no.
10:07
S… Speaker 1 (Voice 002)
The DEG should explain it.
10:09
S… Speaker 1 (Voice 002)
Why do you say it?
10:10
S… Speaker 1 (Voice 002)
Ma'am, the link to the genomics.
10:14
S… Speaker 1 (Voice 002)
The link to the genomics
10:16
S… Speaker 1 (Voice 002)
to the transfer points
10:18
S… Speaker 1 (Voice 002)
to the transfer points.
10:20
S… Speaker 1 (Voice 002)
Try to understand
10:24
S… Speaker 1 (Voice 002)
what you are having and how
10:44
S… Speaker 1 (Voice 002)
the benefits of precision medicine
10:47
S… Speaker 1 (Voice 002)
is an obstacle.
10:48
S… Speaker 1 (Voice 002)
It's a good start.
10:53
S… Speaker 1 (Voice 002)
I'm just sending this
10:55
S… Speaker 1 (Voice 002)
protein, group or a second.
10:57
S… Speaker 1 (Voice 002)
Okay?
11:53
S… Speaker 1 (Voice 002)
Third chapter,
12:00
S… Speaker 1 (Voice 002)
approach is
12:01
S… Speaker 1 (Voice 002)
genomics based,
12:02
S… Speaker 1 (Voice 002)
former genomics,
12:03
S… Speaker 1 (Voice 002)
molecular profiling,
12:04
S… Speaker 1 (Voice 002)
image based precision,
12:06
S… Speaker 1 (Voice 002)
digital health and wearing.
12:10
S… Speaker 1 (Voice 002)
Genomics based
12:11
S… Speaker 1 (Voice 002)
matter
12:16
S… Speaker 1 (Voice 002)
DNA analysis
12:20
S… Speaker 1 (Voice 002)
and
12:23
S… Speaker 1 (Voice 002)
development
12:24
S… Speaker 1 (Voice 002)
and all those things.
12:25
S… Speaker 1 (Voice 002)
Pharmacogenic best approach for precision medicine
12:28
S… Speaker 1 (Voice 002)
is important.
12:30
S… Speaker 1 (Voice 002)
There are terminologies
12:32
S… Speaker 1 (Voice 002)
to explain.
12:36
S… Speaker 1 (Voice 002)
Pharmacogenomics of
12:38
S… Speaker 1 (Voice 002)
which particular genes matter.
12:40
S… Speaker 1 (Voice 002)
are not the same.
12:41
S… Speaker 1 (Voice 002)
This is a good chapter to start.
12:42
S… Speaker 1 (Voice 002)
The third chapter to download.
12:44
S… Speaker 1 (Voice 002)
This is not all things
12:45
S… Speaker 1 (Voice 002)
but you will have to take some.
13:05
S… Speaker 1 (Voice 002)
It's looking for a reworked name
13:25
S… Speaker 1 (Voice 002)
and page.
13:27
S… Speaker 1 (Voice 002)
you.
13:27
S… Speaker 1 (Voice 002)
Thanks.
15:07
S… Speaker 1 (Voice 002)
What is the exact role of injuries and pre-cancers?
15:13
S… Speaker 1 (Voice 002)
Cancer, pregnant, rare genetic disorders, concogements, brain and skin, infectious diseases.
15:21
S… Speaker 1 (Voice 002)
It is a good account.
15:24
S… Speaker 1 (Voice 002)
You can understand the language and infrastructure.
15:31
S… Speaker 1 (Voice 002)
It's not entirely going to cover what you want but it is going to give you sound.
15:36
S… Speaker 1 (Voice 002)
These are three references to sound.
15:42
S… Speaker 1 (Voice 002)
These are four references.
15:44
S… Speaker 1 (Voice 002)
They are not very familiar with the transcripts.
15:51
S… Speaker 1 (Voice 002)
They are roles and precision.
15:54
S… Speaker 1 (Voice 002)
The concept of precision is what is the difference between the detail and the detail.
16:00
S… Speaker 1 (Voice 002)
It's very important.
16:03
S… Speaker 1 (Voice 002)
Okay.
16:05
S… Speaker 2 (Voice 002)
Thank you.
16:06
S… Speaker 2 (Voice 002)
Do you have a lecture?
16:08
S… Speaker 1 (Voice 002)
Yes.
16:09
S… Speaker 2 (Voice 002)
Okay.
16:10
S… Speaker 2 (Voice 002)
Should I send?
16:11
S… Speaker 1 (Voice 002)
Yes.
16:11
S… Speaker 1 (Voice 002)
I am not a doctor.
16:14
S… Speaker 1 (Voice 002)
I am a doctor.
16:16
S… Speaker 1 (Voice 002)
But I will let you know by the end of the day.
16:19
S… Speaker 1 (Voice 002)
Okay.
16:19
S… Speaker 2 (Voice 002)
Should I send?
16:21
S… Speaker 1 (Voice 002)
Yes.
16:22
S… Speaker 2 (Voice 002)
Do you have a presentation?
16:25
S… Speaker 2 (Voice 002)
Yes.
16:26
S… Speaker 1 (Voice 002)
Yes.
16:27
S… Speaker 1 (Voice 002)
Yes.
16:30
S… Speaker 2 (Voice 002)
Thank you.
16:31
S… Speaker 1 (Voice 002)
Yes.
16:40
S… Speaker 2 (Voice 002)
You can tell the left of my age.
16:41
S… Speaker 1 (Voice 002)
What?
16:42
S… Speaker 1 (Voice 002)
Yes.
16:43
S… Speaker 2 (Voice 002)
it looks a little faster

Hierdie transkripsie is deur Kunsmatige spraakerkenning veroorsaak. Kan foute bevat π bevestig teen die oorspronklike oudio vir kritiese gebruik. Kunsmatige inteligensie beleid

❤️ Love STT.ai? Tell your friends!
Opsomming
Mayer is presenting on precision medicine, discussing sub-questions and the differences between personal and precision medicine. He mentions data privacy, risk assessment, and the role of precision medicine in various fields such as agriculture, genome sequencing, and workflow. The presentation covers terminologies like pharmacogenomics and genomics-based approaches.
Ter opsomming...
Vra Kunsmatige inteligensie oor hierdie teks
Vra enigiets oor hierdie transkripsie 0°) die kunsmatige dele en antwoord.